July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
In Conversation
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the…
Interview with Guillaume Bouchara, General Secretary, AGIPHARM – Association des Groupes Internationaux pour la Pharmacie de Recherche
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…
Interview with Jean-Pierre Cassan, Honrary President of the LEEM, LEEM – Les Enterprises du Medicament

Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent…
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion,…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as…
Interview with André Syrota, Director – General, INSERM – l’Institut National de la Santé et de la Recherche Médicale

After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment…
Interview with Henri Vacher, Secretary General, SICOS – Syndicat de l’Industrie Chimique Organique de Synthèses et de la Biochimie

Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the…
Interview with Jean Marimbert, Director General, Agence Française de Sécurité Sanitaire des Produits de Santé

The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the…